Скачать с ютуб Clinical Updates in Alzheimer’s Disease - Treatment for Alzheimer’s Disease: Focus on Anti-amyloid в хорошем качестве

Clinical Updates in Alzheimer’s Disease - Treatment for Alzheimer’s Disease: Focus on Anti-amyloid

Enduring Activity: Clinical Updates in Alzheimer’s Disease Symposium - Treatment for Alzheimer’s Disease: Focus on Anti-amyloid Target Audience This activity is targeted toward physicians, advanced practice providers, nurses and other clinicians. Statement of Need In the care of patients, memory is not always addressed as an integral part of the patient exam unless there is a complaint of memory loss. Therefore, identification of patients with memory loss often is identified later in the course of dementia. This program will equip primary care providers with knowledge of basic cognitive screening tests and brain imaging to identify patients who would benefit from specialized treatment. This would result in earlier diagnosis and treatment of neurodegenerative diseases. Objectives At the conclusion of this offering, the participant will be able to: • Discuss the rationale and mechanism of action of anti-amyloid agents • Review the eligibility criteria for anti-amyloid agents • Review the efficacy and risks associated with anti-amyloid agents Faculty Greg Cooper, MD, PhD Memory and Cognitive Disorders Neurologist Chief, Adult Neurology Medical Director Norton Neuroscience Institute Memory Center Faculty Disclosure The speaker, Greg Cooper, MD, PhD, has no relevant financial relationships with ineligible companies to disclose. Planner & Moderator Disclosure Planners and moderator for this course have no relevant financial relationships with ineligible companies to disclose. Commercial Support This activity has not received commercial support. Physicians Accreditation Norton Healthcare is accredited by the Kentucky Medical Association to provide continuing medical education for physicians. Designation Norton Healthcare designates this live activity for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in this activity. Nursing Credits For more information related to nursing credits, contact Sally Sturgeon, DNP, RN, SANE-A, AFN-BC at (502) 446-5889 or [email protected]. Date of Original Release | June 20, 2024 Course Termination Date | June 2026 Contact Information | Center for Continuing Medical Education; (502) 446-5955 or [email protected] Evaluation https://www.surveymonkey.com/r/Alzhei... Resources Cummings J, Apostolova L, Rabinovici GD, Atri A, Aisen P, Greenberg S, Hendrix S, Selkoe D, Weiner M, Petersen RC, Salloway S. Lecanemab: Appropriate Use Recommendations. J Prev Alzheimers Dis. 2023;10(3):362-377. doi: 10.14283/jpad.2023.30. PMID: 37357276; PMCID: PMC10313141. https://pubmed.ncbi.nlm.nih.gov/37357... Sims JR, Zimmer JA, Evans CD, Lu M, Ardayfio P, Sparks J, Wessels AM, Shcherbinin S, Wang H, Monkul Nery ES, Collins EC, Solomon P, Salloway S, Apostolova LG, Hansson O, Ritchie C, Brooks DA, Mintun M, Skovronsky DM; TRAILBLAZER-ALZ 2 Investigators. Donanemab in Early Symptomatic Alzheimer Disease: The TRAILBLAZER-ALZ 2 Randomized Clinical Trial. JAMA. 2023 Aug 8;330(6):512-527. doi: 10.1001/jama.2023.13239. PMID: 37459141; PMCID: PMC10352931. https://pubmed.ncbi.nlm.nih.gov/37459... Join our online community and stay connected with Norton Healthcare for the latest news, events, and resources to support your well-being. ⬇️ 📘 Facebook:   / nortonhealthcare   📣 X (Twitter):   / norton_health   📸 Instagram:   / nortonhealth   🔗 LinkedIn:   / norton-healthcare   🎥 TikTok:   / nortonhealthcare